Viewing Study NCT04064827


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-23 @ 6:24 AM
Study NCT ID: NCT04064827
Status: TERMINATED
Last Update Posted: 2025-12-04
First Post: 2019-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
Sponsor: AbbVie
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M11-617
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators